SCHEMBL7720955

SCHEMBL7720955

Cc1cc(C(=O)O)ccc1Sc1ccc2c(c1)C(C)(C)CCC2(C)C

nearest known ligand 0.71

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
RXRA P19793 13/20 0.71
RXRB P28702 11/20 0.71
RARB P10826 11/20 0.71
RARG P13631 10/20 0.71
RXRG P48443 9/20 0.71
RARA P10276 9/20 0.53
CYP26A1 O43174 3/20 0.53
CYP26B1 Q9NR63 1/20 0.53
CYP3A4 P08684 1/20 0.50
CRABP2 P29373 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7723496 0.85 RXRA (0.76) RXRARXRBRARBRARGRXRG
SCHEMBL7723487 0.84 RXRA (1.00) RXRARXRBRARBRARGRXRG
SCHEMBL5681933 0.83 RARB (0.82) RXRARXRBRARBRARGRXRG
SCHEMBL1073307 0.83 RXRA (1.00) RXRARXRBRARBRARGRXRG
SCHEMBL8312104 0.82 RXRA (0.57) RXRARXRBRARBRARGRXRG
SCHEMBL29827631 0.79 RARB (0.81) RXRARXRBRARBRARGRXRG
SCHEMBL846110 0.79 RARB (0.81) RXRARXRBRARBRARGRXRG
SCHEMBL8052917 0.79 RXRA (0.55) RXRARXRBRARBRARGRXRG
SCHEMBL7952347 0.78 RARB (0.70) RXRARXRBRARBRARGRXRG
Hydrochloric Acid SCHEMBL9120757 0.77 RARB (0.78) RXRARXRBRARBRARGRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391287-B1 STORAGE STABLE COMPOSITIONS L'OREAL (FR) 2002-05-21 US claimed
EP-1019049-A1 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) USING SPECIFIC RETINOID COMPOUNDS Galderma Research & Development, S.N.C. (FR) 2000-07-19 EP claimed
WO-1998042340-A9 RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS 1999-03-04 WO claimed
WO-1998042340-A1 RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 1998-10-01 WO claimed
US-5766610-A USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-06-16 US claimed
EP-0679630-B1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses CIRD GALDERMA (FR) 1998-05-06 EP claimed
US-6391287-B1 STORAGE STABLE COMPOSITIONS L'OREAL (FR) 2002-05-21 US disclosed
US-6162815-A RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-12-19 US disclosed
US-6156788-A Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-12-05 US disclosed
EP-1019049-A1 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) USING SPECIFIC RETINOID COMPOUNDS Galderma Research & Development, S.N.C. (FR) 2000-07-19 EP disclosed
US-6015569-A PYRIDINE OR PYRROLE DERIVATIVES OF POLYCYCLIC AROMATICS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-01-18 US disclosed
WO-1998042340-A9 RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS 1999-03-04 WO disclosed
WO-1998042340-A1 RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 1998-10-01 WO disclosed
US-5766610-A USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-06-16 US disclosed